N-terminal pro-brain natriuretic peptide levels and diastolic dysfunction in patients with early rheumatoid arthritis before the administration of disease-modifying antirheumatic drugs

N-terminal pro-brain natriuretic peptide levels and diastolic dysfunction in patients with early rheumatoid arthritis before the administration of disease-modifying antirheumatic drugs

Aim. To determine N-terminal pro-brain natriuretic peptide (NT-proBNP) levels in patients with early rheumatoid arthritis (RA) before the use of disease-modifying antirheumatic drugs (DMARDs); to compare NT-proBNP values with traditional risk factors (TRF), cardiovascular diseases (CVD), inflammator...

Full description

Bibliographic Details
Main Authors: I G Kirillova, D S Novikova, T V Popkova, E N Aleksandrova, A A Novikov, Yu N Gorbunova, E I Markelova, Yu O Korsakova, S I Glukhova, A V Volkov, E L Luchikhina, N V Demidova, K A Kasumova, S A Vladimirov, M A Kanonirova, G L Lukina, D E Karateev, E L Nasonov
Format: Article
Language:Russian
Published: "Consilium Medicum" Publishing house 2016-05-01
Series:Терапевтический архив
Subjects:
early rheumatoid arthritis
remarca
nt-probnp
diastolic dysfunction
cardiovascular risk
Online Access:https://ter-arkhiv.ru/0040-3660/article/viewFile/31963/pdf

Internet

https://ter-arkhiv.ru/0040-3660/article/viewFile/31963/pdf

Similar Items